CoQ10, Fibromyalgia, Eating Disorders, and the Importance of Hematological Screening

This recent research on fibromyalgia and eating disorders has increasingly focused on oxidative stress and mitochondrial dysfunction. 

Fibromyalgia, Eating Disorders and Rehabilitation: The Nrf2 Link 
https://www.mdpi.com/2076-3921/15/3/364

Because patients with fibromyalgia often show reduced levels of coenzyme Q10 (CoQ10), supplementation is sometimes suggested as a supportive treatment to improve energy metabolism and reduce cellular stress. Similar metabolic disturbances have also been described in individuals with eating disorders.

However, many studies addressing eating disorders and fibromyalgia focus mainly on metabolic or psychological factors while overlooking potential underlying hematological conditions. This is a significant gap in clinical evaluation.

One example is von Willebrand factor (VWF) abnormalities, which play a central role in blood clotting. Von Willebrand disease and related coagulation disorders are relatively common but often underdiagnosed. Their symptoms can overlap with complex multisystem conditions, and patients may already have additional clotting or bleeding risks that require careful management.

Before recommending supplements such as CoQ10, it is therefore important to assess underlying coagulation status. CoQ10 has structural similarities to vitamin K and may influence coagulation pathways, particularly in individuals with clotting disorders or those receiving anticoagulant therapy.

Despite this, VWF testing is frequently overlooked, especially when patients are primarily treated for eating disorders or chronic pain syndromes. Failing to evaluate hematological factors may lead to incomplete risk assessment and less individualized care.

A more responsible clinical approach would include screening for von Willebrand factor abnormalities and other coagulation markers before initiating supplementation, particularly in patients with complex or unexplained symptoms. Integrating hematological evaluation into the management of fibromyalgia and eating disorders can improve diagnostic accuracy and ensure safer therapeutic decisions.

© 2000-2030 Sieglinde W. Alexander. All writings by Sieglinde W. Alexander have a fife year copy right. Library of Congress Card Number: LCN 00-192742 ISBN: 0-9703195-0-9 

Comments

Popular posts from this blog

Schnitzler Syndrome: A Rare Autoinflammatory Disorder

Acute Flaccid Myelitis (AFM): Understanding the “Polio-like” Illness Affecting the Spinal Cord

Dysferlin Protein: Key Roles, Genetic Locations